Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
The role of miR-200 family in the regulation of hallmarks of cancer
Klaudia Klicka et al.
FRONTIERS IN ONCOLOGY (2022)
Comparative Analysis of Free-Circulating and Vesicle-Associated Plasma microRNAs of Healthy Controls and Early-Stage Lung Cancer Patients
Luigi Pasini et al.
PHARMACEUTICS (2022)
Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer
Chih-Wei Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
Victoria Heredia-Soto et al.
CANCERS (2021)
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
Max M. Wattenberg et al.
BRITISH JOURNAL OF CANCER (2020)
CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia
Anthony Quagliano et al.
BLOOD ADVANCES (2020)
The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si et al.
CLINICAL EPIGENETICS (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential
Manmeet Rawat et al.
GENES (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
Jiangdong Qiu et al.
MOLECULAR CANCER (2018)
Extracellular vesicles in cancer - implications for future improvements in cancer care
Rong Xu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Systematic Methodological Evaluation of a Multiplex Bead-Based Flow Cytometry Assay for Detection of Extracellular Vesicle Surface Signatures
Oscar P. B. Wiklander et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Glimmer of Hope for Pancreatic Cancer
Hedy L. Kindler
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
Michele Reni et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
K. E. Richards et al.
ONCOGENE (2017)
Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma
Zhiyi Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Patterns of Chemotherapy Use in a US-Based Cohort of Patients with Metastatic Pancreatic Cancer
Thomas A. Abrams et al.
ONCOLOGIST (2017)
Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a/Beta-Catenin Axis
Bangli Hu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
Girijesh Kumar Patel et al.
BRITISH JOURNAL OF CANCER (2017)
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Annette Becker et al.
CANCER CELL (2016)
MiR-429 Determines Poor Outcome and Inhibits Pancreatic Ductal Adenocarcinoma Growth by Targeting TBK1
Bin Song et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
T. Golan et al.
BRITISH JOURNAL OF CANCER (2014)
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Sonia A. Melo et al.
CANCER CELL (2014)
miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I
Bin Song et al.
FEBS LETTERS (2014)
MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway
Jian Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration
Lijian Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation
Jun Yu et al.
MOLECULAR CANCER (2010)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Share Paper
